Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT02117375

EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients

Conditions: Multiple Sclerosis

Sex: All
Ages: 18 Years – 40 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 115
Sponsor: Rennes University Hospital

Location: CHU Rennes Rennes

Summary

The purpose of this study is to evaluate the prognostic value of early focal lesions and early diffuse lesions on ambulatory disability progression within 5 years after clinical onset.

Eligibility Criteria

Patients with multiple sclerosis: Inclusion Criteria: * Relapsing Remitting Multiple Sclerosis patients (Mac Donald 2010 criteria) * First clinical event \< 1 year * Brain MRI \> 9 lesions or/and spinal cord attack with focal lesion on spinal cord MRI * Score Expended Disability Status Scale \< 3 * Age between 18 and 40 years Exclusion Criteria: * Multiple Sclerosis progressive * Patients treated with immunosuppressive therapy * Pregnancy Healthy volunteers: Inclusion Criteria: -Age between 18 and 40 years Exclusion Criteria: -Pregnancy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02117375). StuddyBuddy aggregates publicly available trial information.